Carisoprodol Tablet
NDC Package 51525-5901-1
Package Information
Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.Limitation of UseCarisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see Dosage and Administration (2)]. This formulation utilizes a tablet delivery system. Marketed by Mylan Pharmaceuticals Inc., this product is identified by NDC 51525-5901 and is authorized under FDA application NDA011792.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51525 - Mylan Pharmaceuticals Inc.
- 51525-5901 - Carisoprodol
- 51525-5901-1 - 100 TABLET in 1 BOTTLE
- 51525-5901 - Carisoprodol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51525-5901-1 identifies a specific commercial package of 100 tablet in 1 bottle of Carisoprodol, a human prescription drug labeled by Mylan Pharmaceuticals Inc.. This tablet is formulated for oral use and contains carisoprodol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mylan Pharmaceuticals Inc. on October 01, 2016. The current certification is valid through December 31, 2027.
How is this Mylan Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51525590101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.